Tech Company Financing Transactions

Vicept Therapeutics Funding Round

On 6/30/2010, Vicept Therapeutics raised $10 million in Series A funding from F-Prime Capital, Sofinnova Ventures and Vivo Capital.

Transaction Overview

Company Name
Vicept Therapeutics
Announced On
6/30/2010
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors

F-Prime Capital (Lead Investor) (Thomas Beck)

Sofinnova Ventures (Lead Investor) (Anand Mehra)

Vivo Capital (Lead Investor) (Albert Cha)

Proceeds Purpose
Proceeds from the financing will be used to fund Phase I and II development of V-101, the company's lead investigational product for the treatment of rosacea, as well as a second product to treat various forms of bruising and purpura.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
101 Lindenwood Dr. 430
Malvern, PA 19355
USA
Phone
484-324-2930
Website
www.vicepttx.com
Email Address
[email protected]
Overview
icept Therapeutics Inc. is a privately held specialty biopharmaceutical company with a mission to develop the first effective topically applied therapy directed toward the erythema of rosacea and other disorders characterized by redness and or 'flushing' of the skin.
Profile
Vicept Therapeutics LinkedIn Company Profile
Social Media
Vicept Therapeutics Company Twitter Account
Company News
Vicept Therapeutics News
Facebook
Vicept Therapeutics on Facebook
YouTube
Vicept Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Neal Walker
  Neal Walker LinkedIn Profile  Neal Walker Twitter Account  Neal Walker News  Neal Walker on Facebook
Chief Financial Officer
Frank Ruffo
  Frank Ruffo LinkedIn Profile  Frank Ruffo Twitter Account  Frank Ruffo News  Frank Ruffo on Facebook
Chief Operating Officer
Christopher Powala
  Christopher Powala LinkedIn Profile  Christopher Powala Twitter Account  Christopher Powala News  Christopher Powala on Facebook
Chief Scientific Officer
Stuart Shanler
  Stuart Shanler LinkedIn Profile  Stuart Shanler Twitter Account  Stuart Shanler News  Stuart Shanler on Facebook

 

 

Browse more venture capital transactions:

Prev: 6/30/2010: Winster venture capital transaction
Next: 6/30/2010: HelioVolt venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.